# Therapeutic Monitoring of Metformin in Women With Polycystic Ovary Syndrome

> **NCT01366391** · PHASE4 · UNKNOWN · sponsor: **Biocinese** · enrollment: 24 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01366391
- **Lead sponsor:** Biocinese
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2011-08
- **Final completion:** 2011-10
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2011-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01366391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01366391, "Therapeutic Monitoring of Metformin in Women With Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01366391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*